New drug offers hope for rare swelling attacks
NCT ID NCT07290855
First seen Jan 10, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This study tested a drug called icatibant (Icanticure) in 5 adults with a rare condition that causes sudden, painful swelling attacks. The drug is already approved for hereditary angioedema, but this study aimed to gather more safety and effectiveness data for patients who couldn't get the drug through insurance. Participants received the injection during an attack, and researchers measured how quickly symptoms improved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taichung Veterans General Hospital
Taichung, Taiwan
Conditions
Explore the condition pages connected to this study.